Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine in the Pharmacotherapy of Psoriasis
NCT00377325Phase 2Withdrawn
- Sponsor
- University of Rochester
- Start
- Jun 2007
- Primary completion
- Jun 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in psoriasis, sponsored by University of Rochester. Planned start Jun 2007; status: withdrawn.
02
Drugs
cyclosporine
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00377325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377325.